As our previous studies implicated sustained activation of the p38 signaling pathway in mTOR inhibitor resistance [21], we further tested whether alterations in DUSP10 activity would affect PP242 GBM tumor cell responses. The gene discussed is MAPK14; the disease is glioblastoma.